TCMDC-135051

N/A

Report date: 2023/04/20 09:43:36
NME

Base Information

Drug NameTCMDC-135051
Drug Alias NameTCMDC-135051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase PfCLK3 inhibitors
TargetsProtein kinase PfCLK3
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Glasgow
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Glasgow
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A